Resources

Latest Entry
Press Releases
Media Coverage
Scientific Publications
Case Studies
Blog
Media Coverage
March 29th, 2022

Poolbeg Pharma signs first of its kind AI deal with CytoReason

read more
Press Release
February 10th, 2022

CytoReason and Pfizer Extend Collaboration to Leverage Machine Learning in Drug Development

read more
Media Coverage
February 10th, 2022

Pfizer re-ups CytoReason collab applying AI disease models to drug development

read more
Media Coverage
April 16th, 2018

CytoReason uses AI to personalize drugs, opening the door to cancer treatments

read more
Media Coverage
July 19th, 2018

Interview with Systems Immunology Expert Prof. Shai Shen-Orr

read more
Media Coverage
July 17th, 2018

9 AI-based initiatives catalyzing immunotherapy in 2018

read more

Bring your data to life